|
|
CYCLOSPORIN
|
|
|
|
|
|
ANTINEOPLASTICS
|
|
|
Prophylaxis of graft rejection in Organ and tissue transplantation.
|
|
|
Abdominal pain; anorexia; diarrhoea; fatigue; gingival hyperplasia; headache; hepatic dysfunction. Renal dysfunction (renal structural changes on long-term administration).
|
|
|
Ciclosp orin is 10 to 15 mg/kg daily , beginning 4 to 12 hours before
transp lantation, and continued for 1 to 2 weeks. maintenance 2-6 mg/kg daily, reduce dose gradually to maintenance |
|
|
|
|
|
Cyclosporin crosses the placenta; manufacturer advises to avoid unless potential benefit outweighs risk.
|
|
|
Avoid breastfeeding during cyclosporin therapy.
|
|
|
|